placeholder

Female leaders join bit.bio with COO ‘proud of team we’re building’

24/06/2022

Kathryn Corzo took up the role of chief operating officer (COO) at synthetic biology company bit.bio in November.

She joined bit.bio, whose expertise combines coding with biology to provide new human cells for research, she had been a partner at Takeda Ventures Inc, and head of oncology cell therapy development at Takeda Pharmaceuticals. She also served on Takeda’s R&D management committee, was a member of Takeda’s oncology leadership team and served on the board of directors for Maverick Therapeutics which was acquired by Takeda in 2021.

Read the full article here.